Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity
- 6 September 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 129, 106125
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile PharmacophoreJournal of Medicinal Chemistry, 2010
- Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivativesJournal of Enzyme Inhibition and Medicinal Chemistry, 2010
- A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosisJournal of Biological Chemistry, 2010
- Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivativesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Targeting Fatty Acid Biosynthesis for the Development of Novel Chemotherapeutics against Mycobacterium tuberculosis : Evaluation of A-Ring-Modified Diphenyl Ethers as High-Affinity InhA InhibitorsAntimicrobial Agents and Chemotherapy, 2007
- Utilisation of 1,3‐Dicarbonyl Derivatives in Multicomponent ReactionsEuropean Journal of Organic Chemistry, 2004
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Inactivation of the inhA -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatisJournal of Bacteriology, 2000
- Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosisBiochemistry, 1995